Immunoassay Market 1 13

PCR Technologies Market Size to Worth Around USD 14.2 Billion by 2027


[150+ Pages Research Report] According to the recent analysis research report; the global PCR Technologies Market in 2020 was approximately USD 8.1 Billion . The market is expected to grow at a CAGR of 7.0% and is anticipated to reach around USD 14.2 Billion by 2027. Top market players are Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany)

Overview of PCR Technologies Market Study

PCR Technologies market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.

Get your Customized Research Report@

Growth Factors:

The growth PCR technologies market is primarily driven by the rising incidences of target diseases and genetic disorders; continuous technological advancements in PCR technologies, the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project.

PCR Technologies Market Dynamics
Driver: Rising incidence of target infectious diseases and genetic disorders
The demand for genomic analysis techniques has grown steadily during the last decade on the back of their increasing use (microbial identification and detection of genetic mutations) in the diagnosis of major infectious diseases (such as HIV, tuberculosis, malaria, hepatitis, and Staph-related diseases) and genetic disorders (such as cancer and fragile X syndrome). Growth in the prevalence of target diseases globally, coupled with the proven efficacy of PCR analysis in the diagnosis and estimation of disease-causing microbes, will boost the use of clinical diagnostic tests (including qPCR and dPCR analysis) and support market growth.

Restraint: High costs associated with dPCR instruments
A typical PCR analysis conducted through dPCR instruments involves several scientific technologies (PCR, microfluidics, and nanofabrication) integrated to achieve the desired process outcome. These instruments are small and boast reduced cycle times. However, the development of such instruments requires large capital investments and extensive scientific validation on a nanoscale level. Moreover, dPCR is a relatively new technology; as a result, most manufacturers often price their state-of-the-art dPCR instruments at a premium (~USD 120,000) compared to qPCR instruments (~USD 50,000). For instance, as of January 2018, the average price of a dPCR instrument is reported to be USD 55,000–120,000, based on the device architecture and target application areas in the US. Such high prices have resulted in the subdued adoption of dPCR instruments among price-sensitive end users.

Opportunity: Growing market penetration in emerging countries
Emerging markets are expected to offer significant growth opportunities, led by the rising incidence of infectious and chronic diseases, as well as increasing R&D initiatives to develop innovative genomic techniques such as PCR. Growth will be supported by the expansion of healthcare infrastructure, increase in healthcare expenditure, and reducing procedural costs for qPCR-based and dPCR-based disease diagnosis in emerging countries. Emerging countries are witnessing rapid modernization in healthcare facilities and the expansion of healthcare infrastructure. This factor is contributing to the growing demand for clinical diagnostic procedures among diagnostic laboratories, which is resulting in the increased sales of clinical PCR products.

Challenges: Adoption and implementation of MIQE guidelines
Currently, the use of PCR techniques is unregulated globally, which has made end users reluctant to use PCR products in genomic analysis and disease diagnosis. This is mainly due to a non-uniform consensus that exists for the method by which qPCR/dPCR experiments should be conducted to obtain quality results in a time-bound manner. However, there have been attempts to develop guidelines that can streamline and define the minimum requirements needed to carry a PCR-based genomic procedure in a scientific manner with efficient data generation and interpretation. In this regard, the Minimum Information for the Publication of Quantitative Real-time PCR Experiments (MIQE) guidelines were published in the Journal of Clinical Chemistry (April 2009). This included directions for researchers to develop a robust qPCR-based experiment and the evaluation of generated data.

dPCR technique to show the highest growth in the PCR technologies market during the forecast period
The dPCR segment is expected to grow at the highest CAGR in the PCR technologies market. This is due to ongoing technological developments, growing adoption of dPCR products among key end users (compared with qPCR and other PCR products) across mature markets, continued expansion in the distribution networks of major product manufacturers, and growing private funding for developing and commercializing innovative dPCR instruments. Furthermore, dPCR has many potential applications, including the detection and quantification of low-level pathogens, rare genetic sequences, copy number variations (CNVs), and relative gene expression in single cells are also key factors fuelling the demand growth of dPCR instruments among end users.

By end user, hospitals and diagnostic labs hold the largest market share
The hospitals and diagnostic labs segment account for the largest share of the PCR technologies market. Factors such as the increasing market availability of qPCR reagents in clinical diagnostic applications; ongoing expansion of healthcare infrastructure across emerging countries; high prevalence & incidence of target diseases; and growing awareness are driving the growth of this market segment.

Asia Pacific is expected to grow at the highest CAGR in the PCR technologies market during the forecast period
North America is expected to account for the largest share in the global PCR technologies market in 2020. However, healthcare infrastructure modernization, increasing penetration of cutting-edge diagnostic technologies (including PCR technologies) for research and clinical applications, growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment, and the increasing public-private support to develop novel PCR technologies in Asia Pacific countries have accounted for a particularly high growth rate in this region.

Buy Complete Assessment of PCR Technologies market Now@

COVID-19 Impact on PCR Technologies Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the PCR Technologies market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the PCR Technologies market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the PCR Technologies market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the PCR Technologies market include:

Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

PCR technologies Market, by Technique

  • Conventional PCR
    • Real-time PCR (qPCR)
    • Digital PCR (dPCR)
    • Reverse Transcription PCR (RT-PCR)
    • Hot-start PCR
    • Multiplex PCR
    • Other PCR

PCR technologies Market, by Product

  • Instruments
    • Reagents and consumables
    • Software and services

PCR technologies Market, by Application

  • Gene expression analysis
    • Genetic sequencing
    • Genotyping
    • Nucleic acid detection
    • Nucleic acid synthesis
    • Standard validation/verification
    • Diagnostic Applications
    • Environmental Applications
    • Other Applications

PCR technologies Market, by End User

  • Hospitals and diagnostic labs
  • Healthcare industry
  • Academia and government organizations
  • Pharma-biotech companies
  • Applied industries
  • Other end users

Why Buy this Report?

The purpose of Nova one advisor’s PCR Technologies market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333



James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published.